Approximately 85% of HHT cases have heterozygous family-specific mutations in the ENG or ACVRL1 genes encoding endoglin and activin receptor-like kinase 1 (ALK1), members of the transforming growth factor-beta (TGF-β) superfamily. This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.